InjectionClinical Overview
Iron Sucrose Injection (20mg/ml elemental iron, 100mg/5ml ampoule) is a sterile parenteral polynuclear iron(III)-hydroxide sucrose complex on the WHO Model List of Essential Medicines. It exhibits high thermodynamic stability and low toxicity, delivering bioavailable iron directly to transferrin and bone marrow erythroblasts with a very low incidence of anaphylaxis compared to iron dextran. Indicated for treatment of iron deficiency anemia in hemodialysis-dependent and non-dialysis chronic kidney disease, severe gestational anemia, inflammatory bowel disease, and surgical blood management.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administer intravenously only: either by slow IV injection (undiluted at a maximum rate of 20 mg elemental iron per minute, i.e., 5 minutes per 100 mg ampoule) or by IV infusion (100 mg diluted in maximum 100 mL 0.9% NaCl over at least 15 minutes; 200 mg over at least 30 minutes). Monitor patient for at least 30 minutes post-dose. NEVER inject IM.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Hypotension, nausea, dizziness, dysgeusia (metallic taste), injection site burning, headache. Rare/Severe: Severe anaphylactoid reactions, circulatory collapse with rapid injection, and tissue necrosis upon extravasation.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Administer slowly to avoid rapid free iron saturation leading to acute hypotension and peripheral vasodilation. Monitor vital signs during infusion. Extravasation causes brown staining of skin. Contraindicated in iron overload (hemochromatosis) and non-iron deficiency anemias.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.
Syrup of Iron and Folic Acid in a flavoured Base
Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.
Ferrous Ascorbate 100mg and Folic Acid 1.5mg Tablets
Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.
Carbonyl Iron 50mg, Folic Acid 0.5mg and Zinc 61.8mg Capsules
Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.
Haematinic Syrup (Iron, Folic Acid & Vitamin B12)
Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.